Pediatric Neurology Briefs
Published 2004 | Version v1.0.0
Journal Article Open

Extended Efficacy of Once-Daily Atomoxetine in ADHD

Creators

Abstract

The efficacy of atomoxetine administered once daily (final dose 1.3 +/- 0.3 mg/kg; mean 44.5 mg per day; range 10-80 mg per day) in the morning was assessed throughout the day, including evening and early morning, in a total of 197 children, 6 to 12 years of age (71% male), diagnosed with attention-deficit/hyperactivity disorder (ADHD) (69% had combined subtype ADHD, and 35% had comorbid oppositional defiant disorder).

Files

PNB-18-49.pdf

Files (2.8 MB)

Name Size Download all
md5:54ccf80607a64525e5fce7396a959ba5
2.8 MB Preview Download

Additional details

Identifiers

Other
PNB-18-49

Dates

Created
2004
When the item was originally created.